Discovery and Development of Pregabalin (Lyrica)

普瑞巴林 药物开发 医学 收入 食品药品监督管理局 业务 家庭医学 政治学 药理学 药品 精神科 财务
作者
Rachel E. Barenie,Jonathan J. Darrow,Jerry Avorn,Aaron S. Kesselheim
出处
期刊:Neurology [Ovid Technologies (Wolters Kluwer)]
卷期号:97 (17) 被引量:1
标识
DOI:10.1212/wnl.0000000000012730
摘要

Pregabalin (Lyrica), a widely used drug that has generated billions in revenue as a treatment for diabetic neuropathy and other conditions, was originally discovered in an academic medical center, largely supported by public funding. We aimed to define the extent of direct federal public funding that contributed to various stages of pregabalin's development prior to US Food and Drug Administration (FDA) approval.We identified key research, scientists, and organizations involved in the development of pregabalin from its discovery through FDA approval. Using key terms (e.g., its indications and mechanism of action), we searched PubMed for relevant publications and determined whether each publication was based on federal public funding using the NIH RePORTER. For each award prior to the drug's FDA approval, we scored its potential relatedness to pregabalin's development based on its title, investigator, and organization, and then examined descriptions of the most relevant awards to aid in defining these relationships. The budgets for all related awards were converted to 2020 dollars.Pregabalin was discovered largely on the basis of publicly funded research at Northwestern University; in 1990, it was licensed to Parke-Davis, which further developed it through its FDA approval in 2004. Most key terms were related to the drug and drug target (n = 5) and organizations involved (n = 5), followed by patent-listed inventors (n = 3). These key terms linked 6,438 core project awards and we identified 37 NIH awards related to pregabalin's development: 9 awards through 1990 ($3.3 million) and 28 from 1991 through 2004 ($10.5 million).Like that of many other widely sold medications, the development of pregabalin relied on public sector as well as industry contributions to its discovery, with relevant NIH awards totaling $13.8 million during its preapproval development.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
黑森林完成签到,获得积分10
刚刚
秋雅完成签到,获得积分20
刚刚
宁少爷举报自转无风求助涉嫌违规
1秒前
1秒前
1秒前
务实的绝悟完成签到,获得积分10
1秒前
1秒前
Joyj99完成签到,获得积分10
2秒前
金滢发布了新的文献求助10
2秒前
en完成签到,获得积分20
2秒前
kss发布了新的文献求助10
2秒前
烟雨江南完成签到,获得积分10
2秒前
爱撒娇的长颈鹿完成签到,获得积分10
2秒前
bitter发布了新的文献求助10
3秒前
盛夏发布了新的文献求助100
3秒前
可可完成签到,获得积分10
3秒前
4秒前
晓畅完成签到,获得积分10
5秒前
由怜雪发布了新的文献求助10
6秒前
SimmonsLI发布了新的文献求助10
6秒前
酷波er应助天道酬勤采纳,获得10
6秒前
沉静青寒完成签到,获得积分10
7秒前
sunzhou2008完成签到,获得积分10
7秒前
zzz发布了新的文献求助10
7秒前
sia完成签到 ,获得积分10
8秒前
大个应助呆萌棒棒糖采纳,获得10
8秒前
he完成签到,获得积分10
9秒前
9秒前
xueee完成签到,获得积分10
9秒前
大白菜小菜农完成签到 ,获得积分10
10秒前
zhaojian关注了科研通微信公众号
10秒前
落红雨完成签到 ,获得积分10
10秒前
azhu完成签到 ,获得积分10
10秒前
CipherSage应助杰杰屋采纳,获得10
10秒前
ZJY完成签到,获得积分10
11秒前
11秒前
11秒前
12秒前
nicoco完成签到,获得积分10
12秒前
kss完成签到,获得积分10
12秒前
高分求助中
Sustainability in Tides Chemistry 2000
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
Дружба 友好报 (1957-1958) 1000
The Data Economy: Tools and Applications 1000
Mantiden - Faszinierende Lauerjäger – Buch gebraucht kaufen 700
PraxisRatgeber Mantiden., faszinierende Lauerjäger. – Buch gebraucht kaufe 700
A Dissection Guide & Atlas to the Rabbit 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3099914
求助须知:如何正确求助?哪些是违规求助? 2751373
关于积分的说明 7613446
捐赠科研通 2403368
什么是DOI,文献DOI怎么找? 1275253
科研通“疑难数据库(出版商)”最低求助积分说明 616318
版权声明 599053